Adding pembrolizumab to standard-of-care treatment improved event-free survival (EFS) in locally advanced head and neck squamous cell carcinoma (HNSCC), according to new results of the KEYNOTE-689 […]
TOPLINE: Among women aged 70 years or older with screen-detected breast cancer, those with a history of screening mammography within 5 years of their diagnosis were […]
TOPLINE: In a real-world analysis, the relative risk of myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML) was higher in patients who received chemotherapy plus poly(ADP-ribose) […]
A trial testing the combination of the anti-TIGIT antibody tiragolumab and atezolizumab vs atezolizumab in previously untreated programmed cell death ligand 1 (PD-L1)–high locally advanced unresectable […]
TOPLINE: Racial and ethnic disparities in the use of targeted therapy among patients with ERBB2-positive breast cancer decreased among older Medicare beneficiaries between 2010 and 2019. […]
Lingering fatigue and depression are more common among women than men cancer survivors and often lead to a decrease in recreational physical activities in all patients, […]
TOPLINE: A third of patients with high-risk prostate cancer identified as biomarker-negative by an artificial intelligence (AI)–derived tool were safe to forgo long-term androgen deprivation therapy […]
Cervical cancer screening guidelines in the United States have evolved considerably over the past few decades, reflecting advances in understanding how cervical cancer develops, the pivotal […]
The European Medicines Agency’s (EMA) committee on human medicines has approved extended indications for two medicines used to treat Hodgkin disease and leukemia, respectively. In Hodgkin […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.